Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for administrating doxycycline hydrochloride and florfenicol to respiratory tract pathogenic bacteria based on PK/PD model

A technology of doxycycline hydrochloride and florfenicol, which is applied in the direction of antibacterial drugs, medical formulas, drugs or prescriptions, etc., can solve the problems of mixed infection of various diseases, drug resistance, unreasonable selection of drugs, etc., and achieve The effect of mitigating bacterial resistance

Pending Publication Date: 2020-11-24
HUAZHONG AGRI UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] With the increasing resistance of Actinobacillus pleuropneumoniae and Haemophilus parasuis to antibiotics, more and more drugs can no longer be used in the clinical treatment of Actinobacillus pleuropneumoniae and Haemophilus parasuis. Nicholas and doxycycline are widely used in the treatment of porcine respiratory diseases in veterinary clinics due to their broad antibacterial spectrum and strong activity. However, due to the unreasonable selection and abuse of drugs, drug resistance has largely emerged , and the clinical etiology is complex, often manifested as mixed infection of multiple diseases, it is difficult to achieve a good therapeutic effect with a single drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for administrating doxycycline hydrochloride and florfenicol to respiratory tract pathogenic bacteria based on PK/PD model
  • Method for administrating doxycycline hydrochloride and florfenicol to respiratory tract pathogenic bacteria based on PK/PD model
  • Method for administrating doxycycline hydrochloride and florfenicol to respiratory tract pathogenic bacteria based on PK/PD model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] To make the objectives, technical solutions and advantages of the present invention clearer, the technical solutions of the present invention will be described in detail below. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementations obtained by a person of ordinary skill in the art without creative work shall fall within the protection scope of the present invention.

[0036] See Figure 1-Figure 11 As shown, the present invention provides a PK / PD model-based administration method of doxycycline hydrochloride and florfenicol to respiratory pathogenic bacteria, including the following steps:

[0037] Step 1: From the 131 strains of Actinobacillus pleuropneumoniae and 115 strains of Haemophilus parasuis collected in the laboratory as strain samples, determine that doxycycline hydrochloride and florfenicol are effective against...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for administrating doxycycline hydrochloride and florfenicol to respiratory tract pathogenic bacteria based on a PK / PD model. The method comprises the following steps:determining the optimal combined medication proportion of doxycycline hydrochloride and florfenicol on actinobacillus pleuropneumoniae and haemophilus parasuis respectively; under the optimal combined medication proportion of doxycycline hydrochloride and florfenicol, detecting the in-vitro drug sensitivity of doxycycline hydrochloride and florfenicol to actinobacillus pleuropneumoniae and haemophilus parasuis independently and jointly, and counting MIC distribution; and formulating a dosing scheme of the doxycycline hydrochloride and florfenicol injection on actinobacillus pleuropneumoniae and haemophilus parasuis under three dosing purposes of preventing, treating and eradicating diseases, and finally taking the dosing scheme of the component with a relatively small treatment dose in combined medication components as a final dosing scheme.

Description

Technical field [0001] The present invention relates to the technical field of PK-PD model, in particular to a method for administering doxycycline hydrochloride and florfenicol to respiratory pathogenic bacteria based on the PK / PD model. Background technique [0002] Both Actinobacillus pleuropneumoniae and Haemophilus parasuis are highly pathogenic to pigs and pose the greatest threat to the development of the breeding industry. They mainly cause infectious pleuropneumonia, pleurisy and arthritis-based respiratory diseases. [0003] With the increasing resistance of Actinobacillus pleuropneumoniae and Haemophilus parasuis to antibiotics, more and more drugs can no longer be used in the clinical treatment of Actinobacillus pleuropneumoniae and Haemophilus parasuis. Fluorobenzene Nicol and doxycycline are widely used in the treatment of swine respiratory diseases in veterinary clinics due to their broad antibacterial spectrum and strong activity. However, due to unreasonable select...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H20/17G16H50/50G16H50/70G16H10/20A61K31/65A61K31/165A61P31/04
CPCG16H20/17G16H50/50G16H50/70G16H10/20A61K31/65A61K31/165A61P31/04A61K2300/00
Inventor 彭大鹏袁园园瞿玮谢书宇黄玲利郝海红王旭谢长清刘振利
Owner HUAZHONG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products